Sandoz Inc. completed the acquisition of CIMERLI an ophthalmology franchise from Coherus BioSciences, Inc..
Sandoz Inc. completed the acquisition of CIMERLI an ophthalmology franchise from Coherus BioSciences, Inc. (NasdaqGM:CHRS) on March 1, 2024.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.215 USD | -1.56% | +7.52% | -33.48% |
1st Jan change | Capi. | |
---|---|---|
-33.48% | 255M | |
+3.12% | 106B | |
+7.71% | 23.47B | |
-14.98% | 21.9B | |
-6.17% | 18.77B | |
-37.26% | 17.85B | |
-8.21% | 16.78B | |
+7.89% | 14.41B | |
+38.45% | 12.86B | |
+316.58% | 8.78B |